Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 108,657 |
|
|||||
| News | - | ||||||
| Day High | 1.39 | Low High |
|||||
| Day Low | 1.2301 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Enlivex Therapeutics Ltd | ENLV | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.08 | -5.71% | 1.32 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.36 | 1.2301 | 1.39 | 1.32 | 1.40 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 486 | 108,657 | $ 1.34 | $ 146,025 | - | 1.15 - 4.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:21:54 | 1 | $ 1.32 | USD |
Enlivex Therapeutics Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 24.5M | 18.42M | - | 0 | -31.06M | -1.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Enlivex Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENLV Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.89 | 1.93 | 1.15 | 1.46 | 540,987 | -0.57 | -30.16% |
| 1 Month | 3.85 | 4.59 | 1.15 | 2.19 | 379,032 | -2.53 | -65.71% |
| 3 Months | 2.90 | 4.59 | 1.15 | 2.55 | 177,408 | -1.58 | -54.48% |
| 6 Months | 1.37 | 4.59 | 1.15 | 2.57 | 126,378 | -0.05 | -3.65% |
| 1 Year | 2.98 | 4.59 | 1.15 | 2.53 | 75,069 | -1.66 | -55.70% |
| 3 Years | 10.89 | 13.95 | 1.15 | 6.86 | 86,674 | -9.57 | -87.88% |
| 5 Years | 8.67 | 44.90 | 1.15 | 9.88 | 162,098 | -7.35 | -84.78% |
Enlivex Therapeutics Description
| Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. |
